Study Finds NICE Breast Cancer Referral Criteria Miss Most Future Cases in Under-50s
Researchers found family-history referral rules identified fewer than 5% of women who later developed breast cancer, while BOADICEA performed well.
- On Tuesday, August 4, 2026, researchers published findings in the British Journal of Cancer showing NICE referral criteria miss up to 95% of women under 50 who develop breast cancer within a decade.
- Current NICE guidelines rely solely on family history for GP referrals, yet 73% of women under 50 who develop breast cancer have no family history of the disease.
- Using the BOADICEA risk assessment tool, experts identified eight times as many women at risk compared to NICE criteria, with 26.5% of women under 50 classed as above-population level risk.
- NICE welcomed the findings but stated current evidence does not warrant guideline changes, while Professor Montserrat Garcia-Closas warned comprehensive assessment would place heavy burdens on NHS resources.
- Dr. Simon Vincent, chief scientific officer at Breast Cancer Now, stated the research must be considered in future Family History guideline reviews, as public support exists for proactive risk assessment approaches.
22 Articles
22 Articles
Breast Cancer Risk Criteria Miss Nearly All Women Who Later Develop Cancer
Researchers at the University of Cambridge and The Institute of Cancer Research in London have shown that the current UK National Institute for Health and Care Excellence (NICE) breast cancer risk assessment criteria miss over 95% of women under 50 years of age who will develop the disease within 10 years. Compared with the multifactorial risk assessment tool BOADICEA, short for Breast and Ovarian Analysis of Disease Incidence and Carrier Estima…
Revealed: The radical overhaul of cancer screening to detect most at risk
A radical overhaul of Australia’s breast cancer screening will implement a risk-based approach to detect cancers earlier with new technologies beyond mammograms, replacing the current one-size-fits-all, age-based model.
Breast cancer screening misses up to 95% of women under 50 and at high risk
A new risk assessment system called Boadicea, developed by Cambridge and funded by Cancer Research UK identified eight times as many women in the age group who would develop breast cancer in comparison to current guidelines
Transgender people require better breast cancer guidance, study shows
“Every person – transgender or cisgender – deserves clear information about their cancer risk," says researcher Kim Zayhowski The post Transgender people require better breast cancer guidance, study shows appeared first on Attitude.
Coverage Details
Bias Distribution
- 44% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
